Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2005;330 (11 June), doi:10.1136/bmj.330.7504.0-f
| The first 150 words of the full text of this article appear below. |
Question Can hormone replacement therapy (HRT) decrease the risk of urinary incontinence in postmenopausal women?
Synopsis As predicted, more spin-off studies are coming from the women's health initiative multicenter clinical trial of hormone therapy in postmenopausal women. These investigators randomised 27 347 postmenopausal women aged 50-79 to active treatment (oestrogen alone or oestrogen plus progestin) or placebo. The randomisation (concealed allocation assignment) was based on hysterectomy status. Outcomes were assessed by individuals blinded to treatment group assignment. Follow-up was available at one year for 96% of the women. With intention to treat analysis, hormone replacement therapy with oestrogen alone or oestrogen plus progestin increased the risk for urge urinary incontinence (14% v 13%; number needed to harm (NNH) = 100) and stress urinary incontinence (17% v 9%; NNH = 13; 95% CI 10 to 15) compared with placebo.
Bottom line Despite what we learnt about the beneficial effects of hormone
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?